Siloam International Hospitals (SILO) - Net Assets
Based on the latest financial reports, Siloam International Hospitals (SILO) has net assets worth Rp10.54 Trillion IDR (≈ $617.79 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp15.83 Trillion ≈ $927.72 Million USD) and total liabilities (Rp5.29 Trillion ≈ $309.94 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check SILO PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rp10.54 Trillion |
| % of Total Assets | 66.59% |
| Annual Growth Rate | 33.01% |
| 5-Year Change | 52.19% |
| 10-Year Change | 217.31% |
| Growth Volatility | 139.93 |
Siloam International Hospitals - Net Assets Trend (2010–2025)
This chart illustrates how Siloam International Hospitals's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see SILO market cap.
Annual Net Assets for Siloam International Hospitals (2010–2025)
The table below shows the annual net assets of Siloam International Hospitals from 2010 to 2025. Also explore Siloam International Hospitals equity growth rate to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Rp9.93 Trillion ≈ $581.80 Million |
+13.45% |
| 2024-12-31 | Rp8.75 Trillion ≈ $512.81 Million |
+8.75% |
| 2023-12-31 | Rp8.05 Trillion ≈ $471.56 Million |
+14.13% |
| 2022-12-31 | Rp7.05 Trillion ≈ $413.19 Million |
+8.09% |
| 2021-12-31 | Rp6.52 Trillion ≈ $382.28 Million |
+8.40% |
| 2020-12-31 | Rp6.02 Trillion ≈ $352.65 Million |
+0.51% |
| 2019-12-31 | Rp5.99 Trillion ≈ $350.85 Million |
-5.21% |
| 2018-12-31 | Rp6.32 Trillion ≈ $370.13 Million |
+0.05% |
| 2017-12-31 | Rp6.31 Trillion ≈ $369.95 Million |
+101.77% |
| 2016-12-31 | Rp3.13 Trillion ≈ $183.35 Million |
+79.84% |
| 2015-12-31 | Rp1.74 Trillion ≈ $101.95 Million |
+5.22% |
| 2014-12-31 | Rp1.65 Trillion ≈ $96.90 Million |
+0.90% |
| 2013-12-31 | Rp1.64 Trillion ≈ $96.04 Million |
+569.96% |
| 2012-12-31 | Rp244.64 Billion ≈ $14.33 Million |
+36.70% |
| 2011-12-31 | Rp178.96 Billion ≈ $10.49 Million |
+30.08% |
| 2010-12-31 | Rp137.58 Billion ≈ $8.06 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Siloam International Hospitals's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 6177.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rp3.89 Trillion | 40.17% |
| Common Stock | Rp162.58 Billion | 1.68% |
| Other Comprehensive Income | Rp-38.51 Billion | -0.40% |
| Other Components | Rp5.68 Trillion | 58.55% |
| Total Equity | Rp9.70 Trillion | 100.00% |
Siloam International Hospitals Competitors by Market Cap
The table below lists competitors of Siloam International Hospitals ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Henan Lingrui Pharmaceutical Co Ltd
SHG:600285
|
$1.59 Billion |
|
HBIS Resources Co Ltd
SHE:000923
|
$1.59 Billion |
|
Changchun UP Optotech Co Ltd
SHE:002338
|
$1.59 Billion |
|
Jiangsu Expressway Company Limited
F:JE2
|
$1.59 Billion |
|
Kernel Holding SA
WAR:KER
|
$1.58 Billion |
|
Shinkong Insurance Co Ltd
TW:2850
|
$1.58 Billion |
|
Kansai Nerolac Paints Limited
NSE:KANSAINER
|
$1.58 Billion |
|
Transmissora Aliança de Energia Elétrica S.A
SA:TAEE3
|
$1.58 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Siloam International Hospitals's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 8,569,819,000,000 to 9,695,757,000,000, a change of 1,125,938,000,000 (13.1%).
- Net income of 1,112,663,000,000 contributed positively to equity growth.
- New share issuances of 9,156,000,000 increased equity.
- Other comprehensive income increased equity by 41,594,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rp1.11 Trillion | +11.48% |
| Share Issuances | Rp9.16 Billion | +0.09% |
| Other Comprehensive Income | Rp41.59 Billion | +0.43% |
| Other Changes | Rp-37.48 Billion | -0.39% |
| Total Change | Rp- | 13.14% |
Book Value vs Market Value Analysis
This analysis compares Siloam International Hospitals's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.79x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 122.41x to 2.79x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2010-12-31 | Rp16.99 | Rp2080.00 | x |
| 2011-12-31 | Rp22.34 | Rp2080.00 | x |
| 2012-12-31 | Rp28.51 | Rp2080.00 | x |
| 2013-12-31 | Rp188.16 | Rp2080.00 | x |
| 2014-12-31 | Rp174.30 | Rp2080.00 | x |
| 2015-12-31 | Rp185.16 | Rp2080.00 | x |
| 2016-12-31 | Rp329.41 | Rp2080.00 | x |
| 2017-12-31 | Rp574.07 | Rp2080.00 | x |
| 2018-12-31 | Rp483.35 | Rp2080.00 | x |
| 2019-12-31 | Rp456.81 | Rp2080.00 | x |
| 2020-12-31 | Rp458.90 | Rp2080.00 | x |
| 2021-12-31 | Rp497.09 | Rp2080.00 | x |
| 2022-12-31 | Rp704.92 | Rp2080.00 | x |
| 2023-12-31 | Rp607.24 | Rp2080.00 | x |
| 2024-12-31 | Rp657.23 | Rp2080.00 | x |
| 2025-12-31 | Rp746.50 | Rp2080.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Siloam International Hospitals utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.48%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.66%
- • Asset Turnover: 0.89x
- • Equity Multiplier: 1.50x
- Recent ROE (11.48%) is above the historical average (10.23%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2010 | 48.55% | 6.55% | 1.32x | 5.61x | Rp53.58 Billion |
| 2011 | 23.94% | 3.47% | 1.13x | 6.09x | Rp25.47 Billion |
| 2012 | 21.64% | 2.82% | 1.13x | 6.80x | Rp27.14 Billion |
| 2013 | 3.09% | 1.99% | 0.96x | 1.61x | Rp-111.27 Billion |
| 2014 | 3.80% | 1.87% | 1.17x | 1.73x | Rp-102.25 Billion |
| 2015 | 4.04% | 1.70% | 1.39x | 1.71x | Rp-104.01 Billion |
| 2016 | 2.75% | 1.66% | 1.23x | 1.35x | Rp-226.29 Billion |
| 2017 | 1.49% | 1.60% | 0.77x | 1.21x | Rp-535.70 Billion |
| 2018 | 0.26% | 0.27% | 0.78x | 1.22x | Rp-612.47 Billion |
| 2019 | -5.60% | -4.74% | 0.91x | 1.30x | Rp-927.13 Billion |
| 2020 | 1.95% | 1.63% | 0.84x | 1.41x | Rp-480.11 Billion |
| 2021 | 10.46% | 7.19% | 1.01x | 1.44x | Rp29.90 Billion |
| 2022 | 10.01% | 7.32% | 0.98x | 1.39x | Rp947.10 Million |
| 2023 | 15.30% | 10.82% | 1.02x | 1.39x | Rp419.72 Billion |
| 2024 | 10.53% | 7.39% | 0.86x | 1.66x | Rp45.17 Billion |
| 2025 | 11.48% | 8.66% | 0.89x | 1.50x | Rp143.09 Billion |
Industry Comparison
This section compares Siloam International Hospitals's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $1,730,909,074,934
- Average return on equity (ROE) among peers: 3.15%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Siloam International Hospitals (SILO) | Rp10.54 Trillion | 48.55% | 0.50x | $1.58 Billion |
| Bundamedik Tbk PT (BMHS) | $1.80 Trillion | 0.41% | 0.71x | $100.83 Million |
| Metro Healthcare Indonesia (CARE) | $3.10 Trillion | -3.58% | 0.34x | $771.53 Million |
| Medikaloka Hermina PT (HEAL) | $4.69 Trillion | 6.37% | 0.62x | $576.25 Million |
| Lippo Karawaci Tbk (LPKR) | $137.39 Billion | 0.04% | 8.39x | $215.96 Million |
| Mitra Keluarga Karyasehat Tbk PT (MIKA) | $3.64 Trillion | 19.12% | 0.15x | $1.42 Billion |
| Royal Prima PT (PRIM) | $-2.10 Billion | 0.00% | 0.00x | $24.15 Million |
| Kedoya Adyaraya Tbk PT (RSGK) | $815.53 Billion | 3.21% | 0.10x | $56.93 Million |
| Sarana Meditama Metropolitan (SAME) | $850.97 Billion | 1.74% | 0.71x | $293.69 Million |
| Sejahteraraya Anugrahjaya Tbk (SRAJ) | $556.74 Billion | 1.08% | 0.31x | $9.32 Billion |
About Siloam International Hospitals
PT Siloam International Hospitals Tbk operates hospitals and clinics in Indonesia. The company offers general, pre-marital, and lite checkups; male and female screenings; heart, kidney, and cancer screenings; visa application and preemployment screenings; and vaccine and genomic testing services. It also provides diagnostic services, including laboratory and radiology checks; home services; COVID… Read more